Cargando…

Retarding breast tumor growth with nanoparticle-facilitated intravenous delivery of BRCA1 and BRCA2 tumor suppressor genes

Gene augmentation therapy entails replacement of the abnormal tumor suppressor genes in cancer cells. In this study, we performed gene augmentation for BRCA1/2 tumor suppressors in order to retard tumor development in breast cancer mouse model. We formulated inorganic carbonate apatite (CA) nanopart...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibnat, Nabilah, Chowdhury, Ezharul Hoque
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834397/ https://www.ncbi.nlm.nih.gov/pubmed/36631481 http://dx.doi.org/10.1038/s41598-022-25511-9

Ejemplares similares

BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis
por: Li, Qianyan, et al.
Publicado: (2021)

Targeting Cell Adhesion Molecules via Carbonate Apatite-Mediated Delivery of Specific siRNAs to Breast Cancer Cells In Vitro and In Vivo
por: Ashaie, Maeirah Afzal, et al.
Publicado: (2019)

Fabrication and Intracellular Delivery of Doxorubicin/Carbonate Apatite Nanocomposites: Effect on Growth Retardation of Established Colon Tumor
por: Hossain, Sharif, et al.
Publicado: (2013)

Structure-Function of the Tumor Suppressor BRCA1
por: Clark, Serena L., et al.
Publicado: (2012)

BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity
por: Tacconi, Eliana MC, et al.
Publicado: (2017)

Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection
por: Ibrahim, Safinaz S, et al.
Publicado: (2010)

Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats
por: Ibnat, Nabilah, et al.
Publicado: (2022)

Structure and Mechanism of Action of the BRCA2 Breast Cancer Tumor Suppressor
por: Shahid, Taha, et al.
Publicado: (2014)

Cytotoxicity Enhancement in Breast Cancer Cells with Carbonate Apatite-Facilitated Intracellular Delivery of Anti-Cancer Drugs
por: Fatemian, Tahereh, et al.
Publicado: (2018)

Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics
por: Jahan, Sulltana, et al.
Publicado: (2021)

BRCA1 and BRCA2 tumor suppressors in neural crest cells are essential for craniofacial bone development
por: Kitami, Kohei, et al.
Publicado: (2018)

BRCA1 tumor suppressor network: focusing on its tail
por: Wang, Bin
Publicado: (2012)

BRCA1 as tumor suppressor: lord without its RING?
por: Elia, Andrew EH, et al.
Publicado: (2012)

Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1
por: Berthel, Elise, et al.
Publicado: (2020)

Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs
por: Li, Yong Tsuey, et al.
Publicado: (2012)

Surface-Modification of Carbonate Apatite Nanoparticles Enhances Delivery and Cytotoxicity of Gemcitabine and Anastrozole in Breast Cancer Cells
por: Mozar, Fitya Syarifa, et al.
Publicado: (2017)

Carbonate apatite nanoparticles carry siRNA(s) targeting growth factor receptor genes egfr1 and erbb2 to regress mouse breast tumor
por: Tiash, Snigdha, et al.
Publicado: (2017)

Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
por: Lal, Avantika, et al.
Publicado: (2019)

A portable BRCA1-HAC (human artificial chromosome) module for analysis of BRCA1 tumor suppressor function
por: Kononenko, Artem V., et al.
Publicado: (2014)

BRCA1 and p53 Tumor Suppressor Molecules in Alzheimer’s Disease
por: Nakanishi, Atsuko, et al.
Publicado: (2015)

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008)

Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA Repair
por: Minami, Akari, et al.
Publicado: (2014)

PEGylated Strontium Sulfite Nanoparticles with Spontaneously Formed Surface-Embedded Protein Corona Restrict Off-Target Distribution and Accelerate Breast Tumour-Selective Delivery of siRNA
por: Karim, Md. Emranul, et al.
Publicado: (2022)

Carbonate Apatite Nanoparticles-Facilitated Intracellular Delivery of siRNA(s) Targeting Calcium Ion Channels Efficiently Kills Breast Cancer Cells
por: Uddin, Mohammad Borhan, et al.
Publicado: (2018)

Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples
por: Badoer, Cindy, et al.
Publicado: (2016)

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors
por: O’Sullivan, Ciara C., et al.
Publicado: (2014)

Expression profiling of BRCA1 associated breast tumors
por: Berns, EMJJ, et al.
Publicado: (2000)

Methylation of the Tumor Suppressor Protein, BRCA1, Influences Its Transcriptional Cofactor Function
por: Guendel, Irene, et al.
Publicado: (2010)

Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction
por: Tai, Yu Chuan, et al.
Publicado: (2008)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
por: Cipollini, G., et al.
Publicado: (1999)

HP1 promotes tumor suppressor BRCA1 functions during the DNA damage response
por: Lee, Young-Ho, et al.
Publicado: (2013)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
por: Kalachand, Roshni D., et al.
Publicado: (2020)

Insulin-Loaded Barium Salt Particles Facilitate Oral Delivery of Insulin in Diabetic Rats
por: Zaman, Rahela, et al.
Publicado: (2020)

Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells
por: Haque, Sheikh Tanzina, et al.
Publicado: (2020)

Citrate- and Succinate-Modified Carbonate Apatite Nanoparticles with Loaded Doxorubicin Exhibit Potent Anticancer Activity against Breast Cancer Cells
por: Mehbuba Hossain, Sultana, et al.
Publicado: (2018)

Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations
por: Birkbak, Nicolai Juul, et al.
Publicado: (2013)

An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice
por: Ellison, Gillian, et al.
Publicado: (2017)

miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil
por: Pessôa-Pereira, Danielle, et al.
Publicado: (2020)

Switch of FANCL, a key FA-BRCA component, between tumor suppressor and promoter by alternative splicing
por: Yuan, Chengfu, et al.
Publicado: (2012)

The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors
por: Winter, Sherry L, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_hbtgeeqn5smno1r5cm2udnorqt